Stay updated with breaking news from Melissab Epperly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) traded up 7.7% on Tuesday . The stock traded as high as $15.03 and last traded at $15.01. 176,839 shares traded hands during trading, a decline of 78% from the average session volume of 812,871 shares. The stock had previously closed at $13.94. Wall Street Analysts Forecast […]
Kennedy Capital Management LLC boosted its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 2.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 156,475 shares of the company’s stock after purchasing an additional 4,178 shares during the […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Analysts at Leerink Partnrs issued their FY2027 earnings per share estimates for shares of Zentalis Pharmaceuticals in a report released on Tuesday, February 27th. Leerink Partnrs analyst A. Berens anticipates that the company will earn ($2.59) per share for the year. Leerink Partnrs currently has a “Market […]
Federated Hermes Inc. lessened its stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 3.5% in the third quarter, HoldingsChannel.com reports. The firm owned 1,947,693 shares of the company’s stock after selling 70,541 shares during the quarter. Federated Hermes Inc.’s holdings in Zentalis Pharmaceuticals were worth $39,071,000 at the end of the […]
Federated Hermes Inc. cut its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 3.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,947,693 shares of the company’s stock after selling 70,541 shares during the quarter. Federated […]